GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meeting
SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the phase II trial data of KROCUS Study, fulzerasib (GFH925, KRAS G12C inhibitor) in combination with c
Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
MIAMI, June 1, 2024 /PRNewswire/ — Today, Sun Bum made waves in Miami with its largest ever beach hangout, marking the conclusion of Skin Cancer Awareness Month and celebrating the brand’s Just Use Sunscreen campaign – which advocates for sunscreen use regardless of brand choice. The e
LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
MILLIONS TUNED IN FROM ACROSS THE WORLD TO SEE THE LEGENDARY ARTIST’S UNFORGETTABLE PERFORMANCE AHEAD OF THE BIGGEST GAME IN CLUB FOOTBALL Watch the UEFA Champions League final Kick Off Show by Pepsi performance HERE LONDON, June 1, 2024 /PRNewswire/ — #PepsiKickOffShow Rock icon Lenny K
LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
MILLIONS TUNED IN FROM ACROSS THE WORLD TO SEE THE LEGENDARY ARTIST’S UNFORGETTABLE PERFORMANCE AHEAD OF THE BIGGEST GAME IN CLUB FOOTBALL Selection of imagery from the show HERE Watch the UEFA Champions League final Kick Off Show by Pepsi performance HERE LONDON, June 1, 2024 /PRNewswire/ 
Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
-Data demonstrates durable responses across 3 cohorts of patients with recurrent and newly diagnosed GBM- -Data supports continued clinical development of ST101 as a backbone treatment in combination with standard-of-care and immune-oncology agents- TARRYTOWN, N.Y., June 1, 2024 /PRNewswire/ —
Media Advisory – Prime Minister’s itinerary for Sunday, June 2, 2024
OTTAWA, ON, June 1, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
Media Advisory – Deputy Prime Minister’s itinerary for Sunday, June 2, 2024
OTTAWA, ON, June 1, 2024 /CNW/ – Note: All times local. Toronto, Ontario Private meetings. 12:30 p.m. The Deputy Prime Minister will tour a cultural centre and make an announcement. She will be joined by the Minister for Women and Gender Equality and Youth, Marci Ien. A media availability
BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
DALLAS, June 1, 2024 /PRNewswire/ — STEMREGENⓇ, the trailblazer in stem cell science-backed supplements that support the body’s innate repair system, is proud to announce that they’ll be returning for a second year in a row as title sponsor for the 2025 Biohacking Conference, hos
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
CHICAGO, June 1, 2024 /PRNewswire/ — On June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors, announced that the clinical research data for two of its products have been accepted for presentation at the 2024 American Society of Clinical O
Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
GUANGZHOU, China, May 31, 2024 /PRNewswire/ — A news report from GDToday: Organized by the Guangdong Government, the Government of the State of California, Chinese People’s for Friendship with Foreign Countries and California China Climate Institute, the first US-China Bay to Bay Dial
